Unusual weight fluctuation under corticosteroid and psychotropic treatment.
It is generally accepted that corticosteroid therapy may increase weight. Because corticosteroids may induce several psychiatric symptoms, psychotropic drugs are required to treat these symptoms in some cases. The present study describes a patient who had unusual weight fluctuation under corticosteroid and psychotropic treatment such as mianserin and aripiprazole.
Terao
Takeshi
T
Department of Neuropsychiary, Oita University Faculty of Medicine, Yufu, Oita, Japan. terao@med.oita-u.ac.jp
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001066:Appetite / Q000187:drug effects; D000068180:Aripiprazole; D001835:Body Weight / Q000187:drug effects*; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D003866:Depressive Disorder / Q000139:chemically induced* / Q000188:drug therapy*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D004435:Eating / Q000187:drug effects; D005260:Female; D006801:Humans; D008803:Mianserin / Q000009:adverse effects* / Q000627:therapeutic use; D017374:Paroxetine / Q000009:adverse effects / Q000627:therapeutic use; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D011239:Prednisolone / Q000009:adverse effects* / Q000627:therapeutic use; D015363:Quinolones / Q000009:adverse effects* / Q000627:therapeutic use; D020280:Sertraline / Q000009:adverse effects / Q000627:therapeutic use; D013625:Takayasu Arteritis / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D018687:Antidepressive Agents, Second-Generation; D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D008803:Mianserin; D017374:Paroxetine; D000068180:Aripiprazole; D016572:Cyclosporine; D011239:Prednisolone; D020280:Sertraline